Biocon
Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research services space.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Atorvastatin | Atorvastatin | 2022-11-23 | 2037 | |
| Everolimus | Everolimus | 2021-02-11 | 2025-2028 | |
| Fingolimod | Fingolimod | 2019-12-04 | 2027-2032 | |
| Pemetrexed | Pemetrexed | 2022-05-25 | 2035 | |
| Posaconazole | Posaconazole | 2022-02-04 | 2029-2033 | |
| Pravastatin | Pravastatin | 2018-04-13 | ||
| Rosuvastatin | Rosuvastatin | 2016-10-31 | 2033-2036 | |
| Simvastatin | Simvastatin | 2006-12-20 | 2026-2030 | |
| Tacrolimus | Tacrolimus | 2020-11-10 | 2024-2028 | |
| Teriflunomide | Teriflunomide | 2023-03-13 | 2026-2034 | |
| Fulphila | Pegfilgrastim | 2018-06-04 | ||
| Ogivri | Trastuzumab | 2017-12-01 | ||
| Hulio | Adalimumab | 2020-07-06 | ||
| Semglee | Insulin glargine | 2021-07-28 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use